A detailed history of Resource Consulting Group Inc transactions in Astrazeneca PLC stock. As of the latest transaction made, Resource Consulting Group Inc holds 6,350 shares of AZN stock, worth $451,802. This represents 0.07% of its overall portfolio holdings.

Number of Shares
6,350
Holding current value
$451,802
% of portfolio
0.07%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 11, 2024

BUY
$61.89 - $69.28 $393,001 - $439,928
6,350 New
6,350 $427,000
Q2 2023

Jul 14, 2023

BUY
$69.91 - $75.81 $443,928 - $481,393
6,350 New
6,350 $454,000
Q3 2022

Oct 13, 2022

BUY
$53.02 - $135.75 $398,498 - $1.02 Million
7,516 New
7,516 $412,000

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $220B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Resource Consulting Group Inc Portfolio

Follow Resource Consulting Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Resource Consulting Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Resource Consulting Group Inc with notifications on news.